Human amniotic membrane patches to seal inferior retinal breaks
Official title: Prospective Study on the Use of Human Amniotic Membrane (hAM) in the Treatment of Inferior Rhegmatogenous Retinal Detachment (RRD)
Run by Eye & ENT Hospital of Fudan University · NCT07081945 · Data updated 2026-11-12
This trial will try using human amniotic membrane (hAM) patches during vitrectomy to seal inferior retinal breaks in adults with rhegmatogenous retinal detachment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Eye & ENT Hospital of Fudan University Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | July 31, 2026 |
| Study ends | July 31, 2026 |
| Registry record updated | July 28, 2025 |
| Trial ID | NCT07081945 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–70 with primary or recurrent rhegmatogenous retinal detachment that includes inferior retinal breaks between the 4- and 8-o'clock positions or who require an inferior retinotomy are ideal candidates.
✕Probably not a fit
Patients with only anterior retinal breaks or dialysis appropriate for scleral buckling, those with serious pre-existing eye diseases (for example corneal ulcers, glaucoma, or uveitis), or those deemed inappropriate by investigators may not receive benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will perform hAM patch–assisted vitrectomy in 50 adults who have rhegmatogenous retinal detachment with inferior breaks (between 4 and 8 o'clock) or who require an inferior retinotomy. Surgeons will place large hAM grafts over the exposed retinal pigment epithelium using a 'sandwich' technique that allows intraoperative sizing and positioning of the patch. Patients will be followed for at least six months to record retinal reattachment, recurrence, and complications including proliferative vitreoretinopathy. The primary outcome is the single-operation surgical success rate for retinal reattachment after the hAM-assisted procedure.
Why it matters
Potential benefit: If successful, this technique could raise single-operation reattachment rates for inferior RRD and reduce the need for repeat surgeries and postoperative complications.
How similar studies have gone: Small case series and reports have shown intraocular hAM to be safe and promising (including use for macular holes and open-globe injuries) and the sandwich technique may reduce PVR, but larger controlled evidence for inferior RRD is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Subjects having given free and informed consent to take part in the study. 2. Subjects between 18 and 70 years old. 3. Subjects suffering RRD (both primary and recurrent RRDs) with at least one of these conditions: 1. inferior retinal breaks between 4- and 8-o'clock within the detached area regardless of PVR grade; 2. requiring retinotomy inferiorly between 4- and 8-o'clock (due to severe inferior PVR or inferior retinal shortening). Exclusion Criteria: 1. Subjects with RRD with only anterior retina breaks or dialysis and meet the indications for scleral buckling surgery. 2. Subjects with RRD whose retinal breaks located between the 4- and 8-o'clock positions and are not involved in the detached area. 3. Subjects with pre-existing serious eye diseases (corneal ulcers, glaucoma, uveitis, etc). 4. History of epilepsy or serious psychiatric diseases. 5. Other conditions that the researcher found improper to be included into this study.
Where it's running
-
EyeEntFudan
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Zhongcui Sun, PhD.
- Email: zhongcui.sun@aliyun.com
- Phone: +8621-64377134-2501
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effect of Silicone Oil on Retinal Electrical Function Measured by Multifocal ERG
This study tests how silicone oil as a temporary eye tamponade affects retinal function in people with a primary rhegmatogenous retinal detachment.
-
Comparing vitrectomy alone to vitrectomy with cataract removal for retinal detachment
This study is testing whether doing just vitrectomy or adding cataract removal helps older adults with retinal detachment see better and have fewer problems after surgery.
-
Comparing laser and cryotherapy for retinal detachment treatment
This study is testing whether laser treatment or freezing treatment works better for fixing retinal detachment in patients with certain types of retinal tears.
-
Preventing vision loss after retinal detachment surgery with methotrexate
This study is testing if a medication called methotrexate can help prevent vision loss from complications after retinal detachment surgery in adults.
-
Topical netarsudil to prevent scar-like membranes after retinal detachment surgery
This trial will test whether once-daily netarsudil eye drops given before and after vitrectomy can help prevent proliferative vitreoretinopathy (scar tissue) in adults with retinal detachment or established PVR.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.